Different outcome of sarcoglycan missense mutation between human and mouse-Reference-Cited by-同舟云学术

Different outcome of sarcoglycan missense mutation between human and mouse

Published:2018-01-23 Issue:1 Volume:13 Page:e0191274
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Henriques Sara F.,Patissier Cécile,Bourg Nathalie,Fecchio Chiara,Sandona Doriana,Marsolier Justine,Richard Isabelle^ORCID

Funder

AFM-Téléthon

Fondation de France

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference35 articles.

1. Protein misfolding and human disease;N Gregersen;Annual review of genomics and human genetics,2006

2. From dystrophinopathy to sarcoglycanopathy: evolution of a concept of muscular dystrophy;E Ozawa;Muscle & nerve,1998

3. Differential requirement for individual sarcoglycans and dystrophin in the assembly and function of the dystrophin-glycoprotein complex;AA Hack;Journal of cell science,2000

4. epsilon-sarcoglycan replaces alpha-sarcoglycan in smooth muscle to form a unique dystrophin-glycoprotein complex;V Straub;The Journal of biological chemistry,1999

5. The sarcoglycan complex in striated and vascular smooth muscle;MT Wheeler;Cold Spring Harbor symposia on quantitative biology,2002

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rescue of secretion of rare‐disease‐associated misfolded mutant glycoproteins in UGGT1 knock‐out mammalian cells;Traffic;2024-01

2. Modeling Sarcoglycanopathy in Danio rerio;International Journal of Molecular Sciences;2023-08-11

3. Rescue of secretion of a rare-disease associated mis-folded mutant glycoprotein inUGGT1knock-out mammalian cells;2023-05-31

4. CFTR corrector C17 is effective in muscular dystrophy, in vivo proof of concept in LGMDR3;Human Molecular Genetics;2021-09-09

5. A Journey with LGMD: From Protein Abnormalities to Patient Impact;The Protein Journal;2021-06-10